Gempharmatech Co. Ltd. A (688046) — Cash Flow Reinvestment Rate
Gempharmatech Co. Ltd. A (688046) has a Cash Flow Reinvestment Rate of 1.36x as of December 2024, reinvesting CN¥123.04 Million (capex CN¥113.68 Million plus investments CN¥9.36 Million) from operating cash flow of CN¥90.31 Million. See 688046 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gempharmatech Co. Ltd. A Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Gempharmatech Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see Gempharmatech Co. Ltd. A (688046) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Gempharmatech Co. Ltd. A (2019–2024)
Year-by-year capital reinvestment analysis for Gempharmatech Co. Ltd. A. See Gempharmatech Co. Ltd. A leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.36x | CN¥123.04 Million | CN¥90.31 Million | CN¥113.68 Million | ▼ -29.3% |
| 2023 | 1.93x | CN¥224.51 Million | CN¥116.57 Million | CN¥205.90 Million | ▼ -82.8% |
| 2022 | 11.18x | CN¥1.18 Billion | CN¥105.98 Million | CN¥190.31 Million | ▲ +186.1% |
| 2021 | 3.91x | CN¥442.81 Million | CN¥113.31 Million | CN¥89.07 Million | ▲ +69.0% |
| 2020 | 2.31x | CN¥300.17 Million | CN¥129.79 Million | CN¥167.07 Million | ▲ +75.3% |
| 2019 | 1.32x | CN¥85.93 Million | CN¥65.12 Million | CN¥45.66 Million | — |